SG11202008078QA - Treatment and prevention of pre-eclampsia - Google Patents
Treatment and prevention of pre-eclampsiaInfo
- Publication number
- SG11202008078QA SG11202008078QA SG11202008078QA SG11202008078QA SG11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA SG 11202008078Q A SG11202008078Q A SG 11202008078QA
- Authority
- SG
- Singapore
- Prior art keywords
- eclampsia
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18159064 | 2018-02-28 | ||
| PCT/EP2019/055001 WO2019166556A1 (en) | 2018-02-28 | 2019-02-28 | Treatment and prevention of pre-eclampsia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202008078QA true SG11202008078QA (en) | 2020-09-29 |
Family
ID=61521416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202008078QA SG11202008078QA (en) | 2018-02-28 | 2019-02-28 | Treatment and prevention of pre-eclampsia |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20200390872A1 (en) |
| EP (1) | EP3758739B1 (en) |
| JP (1) | JP2021515757A (en) |
| KR (1) | KR20210005549A (en) |
| CN (1) | CN111818938A (en) |
| AU (1) | AU2019226355A1 (en) |
| BR (1) | BR112020017626A2 (en) |
| CA (1) | CA3092163A1 (en) |
| EA (1) | EA202092045A1 (en) |
| ES (1) | ES2982000T3 (en) |
| IL (1) | IL276905A (en) |
| MA (1) | MA52121A (en) |
| MX (1) | MX2020008969A (en) |
| PH (1) | PH12020551331A1 (en) |
| PL (1) | PL3758739T3 (en) |
| SG (1) | SG11202008078QA (en) |
| WO (1) | WO2019166556A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3895726A1 (en) | 2020-04-17 | 2021-10-20 | Pharming Intellectual Property BV | Using c1 esterase inhibitor to treat viral infection-related acute respiratory distress |
| WO2023280981A1 (en) | 2021-07-09 | 2023-01-12 | Pharming Intellectual Property B.V. | Using c1 esterase inhibitor to treat viral infection-related symptoms |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992022320A1 (en) * | 1991-06-14 | 1992-12-23 | Genentech, Inc. | C1 inhibitor variants and treating inflammatory response with c1 inhibitor |
| GB9618931D0 (en) * | 1996-09-11 | 1996-10-23 | Univ London | Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes |
| US7067713B2 (en) * | 2000-01-31 | 2006-06-27 | Pharming Intellectual Property B.V. | C1 Inhibitor produced in the milk of transgenic non-human mammals |
| DK1252184T3 (en) * | 2000-01-31 | 2008-02-04 | Pharming Intellectual Pty Bv | Human C1 inhibitor produced in milk by transgenic animals |
| GB0015625D0 (en) * | 2000-06-26 | 2000-08-16 | Univ London | Materials and methods relating for the treatment and diagnosis of pre-eclampsia |
| BRPI0312818B8 (en) * | 2002-07-19 | 2021-05-25 | Beth Israel Deaconess Medical Ct Inc | using a measure of the level of the sflt-1 polypeptide in a patient sample and using a measure of the levels of at least two of the sflt1, free vegf, or free pigf polypeptide in a patient sample using a metric |
| US20050255114A1 (en) * | 2003-04-07 | 2005-11-17 | Nuvelo, Inc. | Methods and diagnosis for the treatment of preeclampsia |
| USRE43691E1 (en) * | 2003-05-16 | 2012-09-25 | Pharming Intellectual Property B.V. | C1 inhibitor with short half-life transient treatment |
| US20060067937A1 (en) * | 2004-09-24 | 2006-03-30 | Karumanchi S A | Methods of diagnosing and treating complications of pregnancy |
| PT1965831E (en) * | 2005-12-21 | 2011-10-19 | Pharming Intellectual Pty Bv | Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| SI2380587T1 (en) | 2005-12-21 | 2018-03-30 | Pharming Intellectual Property B.V. | Use of C1 inhibitor for the prevention of ischemia-reperfusion injury |
| CN104870475B (en) * | 2012-10-25 | 2019-11-08 | 美国比奥维拉迪维股份有限公司 | Anticomplement C1s antibody and its purposes |
| US20150330989A1 (en) * | 2012-11-15 | 2015-11-19 | The Brigham And Women's Hospital, Inc. | Method and system for diagnosing and treating preeclampsia |
| EP2968434B1 (en) | 2013-03-15 | 2017-06-28 | Shire Viropharma Incorporated | C1-inh compositions for use in the prevention and treatment of hereditary angioedema (hae). |
| WO2016081889A1 (en) * | 2014-11-21 | 2016-05-26 | Kurt Baekgaard Osther | Recombinant c1 esterase inhibitor and use thereof |
| MA45473A (en) | 2016-04-04 | 2019-02-13 | Shire Human Genetic Therapies | CONJUGATE C1 ESTERASE INHIBITOR AND ITS USES |
| EP3895726A1 (en) * | 2020-04-17 | 2021-10-20 | Pharming Intellectual Property BV | Using c1 esterase inhibitor to treat viral infection-related acute respiratory distress |
-
2019
- 2019-02-28 PL PL19708487.4T patent/PL3758739T3/en unknown
- 2019-02-28 BR BR112020017626-5A patent/BR112020017626A2/en unknown
- 2019-02-28 KR KR1020207026466A patent/KR20210005549A/en not_active Application Discontinuation
- 2019-02-28 SG SG11202008078QA patent/SG11202008078QA/en unknown
- 2019-02-28 AU AU2019226355A patent/AU2019226355A1/en not_active Abandoned
- 2019-02-28 US US16/975,725 patent/US20200390872A1/en active Pending
- 2019-02-28 CN CN201980015668.4A patent/CN111818938A/en active Pending
- 2019-02-28 EP EP19708487.4A patent/EP3758739B1/en active Active
- 2019-02-28 CA CA3092163A patent/CA3092163A1/en active Pending
- 2019-02-28 JP JP2020545346A patent/JP2021515757A/en active Pending
- 2019-02-28 MA MA052121A patent/MA52121A/en unknown
- 2019-02-28 ES ES19708487T patent/ES2982000T3/en active Active
- 2019-02-28 EA EA202092045A patent/EA202092045A1/en unknown
- 2019-02-28 MX MX2020008969A patent/MX2020008969A/en unknown
- 2019-02-28 WO PCT/EP2019/055001 patent/WO2019166556A1/en active Application Filing
-
2020
- 2020-08-24 IL IL276905A patent/IL276905A/en unknown
- 2020-08-26 PH PH12020551331A patent/PH12020551331A1/en unknown
-
2024
- 2024-05-06 US US18/655,414 patent/US20240285736A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2020008969A (en) | 2021-02-16 |
| WO2019166556A1 (en) | 2019-09-06 |
| US20240285736A1 (en) | 2024-08-29 |
| EP3758739A1 (en) | 2021-01-06 |
| PL3758739T3 (en) | 2024-09-16 |
| CN111818938A (en) | 2020-10-23 |
| CA3092163A1 (en) | 2019-09-06 |
| EP3758739B1 (en) | 2024-05-15 |
| EA202092045A1 (en) | 2020-11-09 |
| BR112020017626A2 (en) | 2020-12-22 |
| US20200390872A1 (en) | 2020-12-17 |
| KR20210005549A (en) | 2021-01-14 |
| IL276905A (en) | 2020-10-29 |
| PH12020551331A1 (en) | 2021-09-06 |
| MA52121A (en) | 2021-06-02 |
| JP2021515757A (en) | 2021-06-24 |
| ES2982000T3 (en) | 2024-10-14 |
| EP3758739C0 (en) | 2024-05-15 |
| AU2019226355A1 (en) | 2020-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277648A (en) | Therapeutic microbiota for the treatment and/or prevention of food allergy | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| EP3706736A4 (en) | Ash1l degraders and methods of treatment therewith | |
| ZA202000558B (en) | Prevention and/or treatment of neurodegenerative disease | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| IL275925A (en) | Prevention and treatment of organ fibrosis | |
| IL276905A (en) | Treatment and prevention of pre-eclampsia | |
| GB201616009D0 (en) | Treatment and/or prevention of sepsis | |
| PT3708174T (en) | Methods and treatment of trauma | |
| ZA202002669B (en) | Prevention and treatment of graft-versus-host-disease with defensins | |
| ZA201906964B (en) | Prevention and/or treatment of inflammatory skin disease | |
| GB201522329D0 (en) | Use of adjuvants for the prevention and/or treatment of autoimmune diseases | |
| EP3525771A4 (en) | Prevention and/or treatment of contrast-induced acute kidney injury | |
| IL268860A (en) | Granzyme b inhibitor compositions and methods for the prevention and/or treatment of skin blistering and/or peeling | |
| IL256675A (en) | Methods and compositions for prevention and treatment of pressure ulcers | |
| GB201815000D0 (en) | Treatment of hypothroidism and related conditions | |
| GB201815694D0 (en) | Prevention and treatment of cancer | |
| GB201809946D0 (en) | Prevention and treatment of cancer | |
| GB2603379B (en) | Avocatin B for the treatment of diseases and conditions | |
| SG11202009295YA (en) | Treatment and prophylaxis of amyloidosis | |
| IL282686A (en) | Treatment and prevention of premature ejaculation (pe) | |
| GB201816542D0 (en) | Treatment and prevention of malaria | |
| EP3893861C0 (en) | Treatment and prevention of glioblastoma | |
| IL276121A (en) | Treatment and prevention of seed allergies |